← Eichor
Study identifier: NCT07500116 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

NORA-HOME: An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks

Condition: Stroke (CVA) or TIA · Stroke Recurrence  ·  Sponsor: Hospital Universitari Vall d'Hebron Research Institute

PhaseNA
Planned participants250
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

In this project, we aim to validate a Home Hospitalization plan for patients with TIA or minor stroke. Our hypothesis is that our Multimodal Home Hospitalization program (NORAHOME) for patients with TIA and minor stroke is safe, reduces the complications associated with conventional hospitalization, and is more efficient than Standard Clinical Practice. To conduct the study, we require the voluntary participation of patients with TIA and minor strokes.

This description comes directly from the study's public registry record.

Talk to the study team

Marian Muchada Lopez, MD, PHD  ·  +34 934893000  ·  mangeles.muchada@vallhebron.cat

Marta Rubiera del Fueyo, MD, PhD  ·  +34934893000  ·  martaaurora.rubiera@vallhebron.cat

Always discuss trial participation with your own doctor first.

Locations (1)

Vall Hebron University HospitalBarcelona, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07500116